Adı Soyadı                         :  Prof.Dr. Necla (EREN) TÜLEK
Doğum Yeri ve Tarihi       :  Ankara (Nallıhan)
Uzmanlık Alanı - 1           :  Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji
Uzmanlık Alanı - 2           :  İmmünoloji (yan dal)
Unvanı                               :  Profesör Doktor
Mezun olduğu Okul-Yıl  :  Hacettepe Üniversitesi Tıp Fakültesi, 1980
Çalıştığı Klinik-Bölüm     :  Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji
Bildiği Yabancı Dil           :  İngilizce
Medeni Durumu             :  Evli, bir oğlu var

Eğitimleri       
Derece
Bölüm/Program
Üniversite
Yıl
Y. Lisans
Tıp Fakültesi
Hacettepe Üniversitesi
1980
Tıpta Uzmanlık 1
Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji
Enfeksiyon Hastalıkları
ve Klinik Mikrobiyoloji Kliniği,
Sağlık Bakanlığı Ankara Eğitim
ve Araştırma Hastanesi
1985
Tıpta Uzmanlık 2
İmmunoloji
Ankara Üniversitesi Tıp Fakültesi
1996
Doçent
Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji
Ankara Üniversitesi Tıp Fakültesi
1999
Profesör
Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji
Ondokuz Mayıs Üniversitesi Tıp Fakültesi
2005

Görevler                            
Görev Unvanı

Görev Yeri

Yıl
Dr.
Başhekim
Ankara Nallıhan Devlet Hastanesi
1980-1981
Dr.
Araştırma Görevlisi
Sağlık Bakanlığı Ankara Eğitim ve Araştırma Hastanesi, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Kliniği 
Hacettepe Üniversitesi Tıp Fakültesi Mikrobiyoloji
1981-1985

1983-1984
Uzman Dr.
SSK Ordu Hastanesi zorunlu hizmet
1986-1990
Uzman Dr.
Klinik Şef Yardımcısı
SSK Ankara Eğitim Hastanesi
Mikrobiyoloji ve Klinik Mikrobiyoloji
1990-1991
1994-1999
Uzman Dr.
Araştırma Görevlisi
Ankara Üniversitesi Tıp Fakültesi İç Hastalıkları İmmünoloji
1991-1994
Doçent
Klinik Şefi
Sağlık Bakanlığı Ankara Eğitim ve Araştırma Hastanesi, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Kliniği 
1999-2004
Doçent
Anabilim Dalı Başkanı
Ondokuz Mayıs Üniversitesi Tıp Fakültesi Acil Anabilim Dalı
2004-2005
Profesör
Öğretim Üyesi
Ondokuz Mayıs Üniversitesi Tıp Fakültesi,
Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji
2005-2006
Profesör
Anabilim Dalı Başkanı
Ondokuz Mayıs Üniversitesi Tıp Fakültesi, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji
2006-2009
Profesör
Klinik Şefi
Eğitim Görevlisi
Sağlık Bakanlığı Ankara Eğitim ve Araştırma Hastanesi, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Kliniği 
2009-2011
2011-

Gönderen Necla Eren TÜLEK, MD Professor 25 Şubat 2018 Pazar


 SCI (SCIENCE CITATION INDEX), SCI-E (SCI-EXPANDED) TARAFINDAN TARANAN DERGILERDE YAYIMLANAN YAYINLAR:

1- Ali Asan, Murat Sayan, Sila Akhan, Suda Tekin Koruk, Bilgehan Aygen, Fatma Sirmatel, Haluk Eraksoy , Nazan Tuna,  Sukran Köse, Ali Kaya, Necla Eren Tulek,  Nazlim Aktug Demir, Resit Mistik, Bahar Ormen,  Fatime Korkmaz,  Taner Yildirmak, Onur Ural, Mehtap Aydin, Huseyin Turgut, Ozgur Gunal, Nese Demirturk. Molecular Characterization of Drug Resistance in Hepatitis B Viruses Isolated from Chronically Infected Patients in Turkey, Hepat Mon. 2018; 18(1):e12472. doi: 10.5812/hepatmon.12472.

2-  Ünal S, Yayla Ç, Açar B, Ertem AG, Akboğa MK, Gökaslan S, Erdöl MA, Sönmezer MÇ, Kaya Kiliç E, Ataman Hatipoğlu Ç, Tulek N, Erdinç FS, Aydoğdu S, Temizhan A. Tp-e interval and Tp-e/QT ratio in patients with Human Immunodeficiency Virus. J Infect Public Health. 2018 Jan - Feb; 11(1):35-38.

3- Pinar Korkmaz,1,* Nese Demirturk,2 Ayse Batırel,3 Ahmet Cem Yardimci,4 Unal Cagir,5 Salih Atakan Nemli,6 Fatime Korkmaz,7 Fusun Zeynep Akcam,8 Huseyin Sener Barut,9 Burcu Bayrak,10 Faruk Karakecili,11 Huseyin Tarakci,12 ZerrinYulugkural,13 Esma Yuksel,14 Nazlım Aktug Demir,15 Onur Ural,15 Sua Sumer,15 Rezan Harman,16 Ayten Kadanali,17 Sinan Ozturk,17 Sila Cetin Akhan,18 Necla Eren Tulek,19 Derya Keten,20 Alper Sener,21 Bilgehan Aygen,22 Aysel KocagulCelikbas,23 Fatma Yilmaz Karadag,24 Gule Aydin,25 Eyup Arslan,26 Cahide Sacligil,27 Gulfem Akengin Ocal,27 Alpaslan Tanoglu,28 Asim Ulcay,29 Ergenekon Karagoz,29 Nese Saltoglu,30 Fatma Sırmatel,31 Hayrettin Akdeniz,31 Aynur Aynıoglu,32 Selcan Arslan Ozel,33 Selmin Dirgen Caylak,34 Ilhami Celik,35 Yesim Alpay,36 Zehra Bestepe Dursun,35 Muhammed Bekcibasi,37 Gunay Tuncer Ertem,19 Arzu Tigli,38 Elif Sargin Altunok,39 Kemal Avsar,38 Kaya Suer,40 and MuratSayan41 . Noninvasive Models to Predict Liver Fibrosis in Patients with Chronic Hepatitis B: A Study from Turkey, Hepat Mon. 2017 ;17(12):e60266. doi: 10.5812/hepatmon.60266.

4- Tanriover MD, Bagci Bosi T, Ozisik L, Bilgin E, Güzel Tunçcan Ö, Özgen Ö, Tülek N, Özsoy M, Tezer H, Bedir Demirdağ T, Kara A, Basaranoglu ST, Aykac K, Ozkaya-Parlakay A, Gulhan B, Unal S. Poor outcomes among elderly patients hospitalized for influenza-like illness. Curr Med Res Opin. 2017 Oct 16:1-7. doi: 10.1080/03007995.2017.1381078

5-  Ertem AG, Yayla Ç, Açar B, Ünal S, Erdol MA, Sonmezer MÇ, Kaya Kiliç E, Ataman Hatipoglu Ç, Gokaslan S, Kafes H, Akboga MK, Aladag P, Demirtas K, Tulek N, Erdinç FS, Aydogdu S. Assessment of the atrial electromechanical properties of patients with human immunodeficiency virus. J Infect Public Health. 2017 Nov - Dec; 10(6):721-724.

6- MÇ Sönmezer, Ş. Erdinç, N Tülek, C Babür, A. Büyükdemirci, T İlgar, G Ertem. Cutaneous larva migrans in Turkey: an imported case report. Mikrobiol Bul. 2017; 51(1): 94-9.

7- Temocin F, Sari T, Tulek N. Sandfly Fever with Skin Lesions: A Case Series from Turkey. J Arthropod-Borne Dis 2016, 10(4): 608–12.

8- Ertem G, Sönmezer MÇ, Temoçin F, Ataman Hatipoğlu Ç, Tülek N, Oral B. The efficacy of oral ribavirin on clinical and laboratory parameters in Crimean-Congo hemorrhagic fever: an observational study from Turkey. Turk J Med Sci 2016: 17; 46(5): 1407-14.

9-  Sonmezer MC, Ertem G, Erdinc FS, Kaya Kilic E, Tulek N, Adiloglu A, Hatipoglu C. Evaluation of Risk Factors for Antibiotic Resistance in Patients with Nosocomial Infections Caused by Pseudomonas aeruginosa. Can J Infect Dis Med Microbiol 2016; 2016: 1321487. doi: 10.1155/2016/1321487. Epub 2016 Aug 30.

10- Yildirmak T, Tulek N, Bulut C. Crimean-Congo haemorrhagic fever: transmission to visitors and healthcare workers. Infection 2016; 44(5): 687-9.

11- Gürbüz Y, Tülek N, Emin Ediz Tütüncü E, et al. Evaluation of Dual Therapy in Real Life Setting in Treatment-Naïve Turkish Patients with HCV Infection: A Multicenter, Retrospective Study. Balkan Med J 2016; 33:18-26.

12- Temocin F, Erdinc FS, Tulek N, et al. Incidence and Risk Factors for Colistin-Associated Nephrotoxicity. Jpn J Infect Dis 2015; 68, 318–20.

13- Temocin F, Erdinc FS, Tulek N, et al Synergistic effects of sulbactam in multi-drug-resistant Acinetobacter baumannii. Braz J Microbiol 2015; 46(4):1119-24.

14- Tekin Koruk S, Batirel A, Kose S, Cetin Akhan S, Aygen B, Tulek N, Hatipoglu Ç, Bulut C, Yıldız O, Sacligil C, Sirmatel F, Altunok E. Evaluation of hepatitis B virus transmission and antiviral therapy among hepatitis B surface antigen-positive pregnant women. J Obstet Gynaecol Res 2015 Dec; 41(12):1870-6.

15- Sari T, Tulek N, Bulut C, Oral B, Tuncer Ertem G. Adverse events following rabies post-exposure prophylaxis: A comparative study of two different schedules and two vaccines. Travel Med Infect Dis 2014; 12: 659-66.

16- Erdem H, Ozturk-Engin D, Yesilyurt M, Karabay O, Elaldi N, Celebi G, Korkmaz N, Guven T, Sumer S, Tulek N, Ural O, Yilmaz G, Erdinc S, Nayman-Alpat S, Sehmen E, Kader C, Sari N, Engin A, Cicek-Senturk G, Ertem-Tuncer G, Gulen G, Duygu F, Ogutlu A, Ayaslioglu E, Karadenizli A, Meric M, Ulug M, Ataman-Hatipoglu C, Sirmatel F, Cesur S, Comoglu S, Kadanali A, Karakas A, Asan A, Gonen I, Kurtoglu-Gul Y, Altin N, Ozkanli S, Yilmaz-Karadag F, Cabalak M, Gencer S, Umut Pekok A, Yildirim D, Seyman D, Teker B, Yilmaz H, Yasar K, Inanc Balkan I, Turan H, Uguz M, Kilic S, Akkoyunlu Y, Kaya S, Erdem A, Inan A, Cag Y, Bolukcu S, Ulu-Kilic A, Ozgunes N, Gorenek L, Batirel A, Agalar C. Evaluation of tularaemia courses: a multicentre study from Turkey. Clin Microbiol Infect 2014 Dec; 20(12):O1042-51.

17- Erdem H, Inan A, Elaldi N, Tekin R, Gulsun S, Ataman-Hatipoglu C, Beeching N, Deveci O, Yalci A, Bolukcu S, Dagli O; Umut Pekok A, Erayman I, Kaptan F, Kaya S, Cilli A, Batirel A, Kurtaran B, Ulug M, Aygen B, Cabalak M, Cetin B, Cicek-Senturk G, Duygu F, Engin A, Necati Hakyemez I, Kayabas U, Kazak E, Sahin-Horasan E, Sipahi OR, Sirmatel F, Tosun S, Akkoyunlu Y, Ozturk-Engin D, Tulek N, Kocak N, Mert G, Eray Gokce D, Cem Gul H, Hosoglu S, Dayan S, Gorenek L, Aslan T, Kurt H, Bitirgen M. Respiratory system involvement in Brucellosis: The results of the Kardelen Study. Chest. 2013 Aug 1. doi: 10.1378/chest.13-0240. Online suppl.

18- Ozturk-Engin D, Erdem H, Gencer S, Kaya S, Baran AI, Batirel A, Tekin R, Celen MK, Denk A, Guler S, Ulug M, Turan H, Pekok AU, Mermut G, Kaya S, Tasbakan M, Tulek N, Cag Y, Inan A, Yalci A, Ataman-Hatipoglu C, Gonen I, Dogan-Celik A, Bozkurt F, Gulsun S, Sunnetcioglu M, Guven T, Duygu F, Parlak E, Sozen H, Tosun S, Demirdal T, Guclu E, Karabay O, Uzun N, Gunal O, Diktas H, Haykir-Solay A, Erbay A, Kader C, Aydin O, Erdem A, Elaldi N, Kadanali A, Yulugkural Z, Gorenek L, Altındis M, Bolukcu S, Agalar C, Ormeci N. Liver involvement in patients with brucellosis: results of the Marmara study. Eur J Clin Microbiol Infect Dis. 2014 Jul; 33(7):1253-62.

19- Erdem H, Elaldi N, Ak O, Gulsun S, Tekin R, Ulug M, Duygu F, Sunnetcioglu M, Tulek N, Guler S, Cag Y, Kaya S, Turker N, Parlak E, Demirdal T, Ataman Hatipoglu C, Avci A, Bulut C, Avci M, Pekok A, Savasci U, Kaya S, Sozen H, Tasbakan M, Guven T, Bolukcu S, Cesur S, Horasan ES, Kazak E, Denk A, Gonen I, Karagoz G, Haykir Solay A, Alici O, Kader C, Senturk G, Tosun S, Turan H, Baran AI, Ozturk-Engin D, Bozkurt F, Deveci O, Inan A, Kadanali A, Sayar MS, Cetin B, Yemisen M, Naz H, Gorenek L, Agalar C. Genitourinary brucellosis: results of a multicentric study. Clin Microbiol Infect. 2014 Nov; 20(11):O847-53.

20- Ergin F, Tülek NE, Yetkin MA, Bulut C, Oral B, Tuncer Ertem G. Evaluation of Candida colonization in intensive care unit patients and the use of Candida colonization index]. Mikrobiyol Bul 2013; 47: 315-7.

21- Erdem F, Tuncer Ertem G, Oral B, Karakoç E, Demiröz AP, Tülek N. Epidemiological and microbiological evaluation of nosocomial infections caused by Candida species. Mikrobiyol Bul. 2012 Oct; 46(4):637-48.

22- Koruk ST, Erdem H, Koruk I, Erbay A, Tezer-Tekce Y, Erbay AR, Dayan S, Deveci O, Inan A, Engin DO, Guner R, Dikici N, Doyuk-Kartal E, Kurtaran B, Pehlivanoglu F, Sipahi OR, Yalci A, Yemisen M, Alp-Cavus S, Gencer S, Guzel G, Oncul O, Parlak M, Kazak E, Tulek N, Ulcay A, Savasci U. Management of Brucella endocarditis: results of the Gulhane study. Int J Antimicrob Agents. 2012 Aug; 40(2):145-50.

23- Ertugrul BM, Oncul O, Tulek N, Willke A, Sacar S, Tunccan OG, Yilmaz E, Kaya O, Ozturk B, Turhan O, Yapar N, Ture M, Akin F. A prospective, multi-center study: factors related to the management of diabetic foot infections. Eur J Clin Microbiol Infect Dis 2012 Sep; 31(9):2345-52

24- Erdem H, Ulu A, Kilic S, Karahocagil M, Sheeta G, Eren-Tulek N, et al. The Efficacy and Tolerability Of Antibiotic Combinations In Neurobrucellosis: Results Of The Istanbul Study. Antimicrob Agents Chemother. 2012 Mar; 56(3):1523-8.

25- Bulut C, Yetkin MA, Yılmaz G, Erdinç FS, Ataman Hatipoğlu Ç, Kınıklı S, Oral B, Tülek N, Demiröz AP. Assessment of the findings on the existence of complicatons in brucellosis. Turk J Med Sci 2011; 41(2):275-82.

26- Yıldız O, Aygen B, Demirtürk N, Demirdal T, Inan D, Yıldırmak T, Kantürk A, Tütüncü E; Hepatitis B Study Group. Collaborators (15)Akhan S, Ayaz C, Çelen M, Baykam N, Hızel K, Kayabas U, Kokoglu OF, Ucmak H, Kose S, Mıstık R, Oncul O, Saltoglu N, Savas L, Onlen Y, Tulek N. Lamivudine resistance mutations in patients infected with hepatitis B virus genotype D. World J Gastroenterol 2011 Dec 7; 17(45):4987-92. ( as a member of study group)

27- Erdem H, Tekin-Koruk S, Koruk I, Tozlu-Keten D, Ulu-Kılıc A, Oncul O, Guner R, Birengel S, Mert G, Nayman-Alpat S, Eren-Tulek N, et al. Assessment of the requisites of microbiology based infectious disease training under the pressure of consultation needs. Ann Clin Microbiol Antimicrob. 2011 Dec 16; 10(1):38.

28- N Tasdelen Fısgin, L.Doganci, E. Tanyel and N. Tulek. Inıtial high rate of misdiagnosis in Crimean Congo haemorhagic fever patients in an endemic region of Turkey. Epidemiol Infect 2010; 139-44.

29- E. Tanyel, AY Coban, N Tasdelen Fisgin, N.Tulek. The effect of tigecycline and ertapenem against clinical isolates of Brucella melitensis detected by E-test on different media. Indian J Med Microbiol 2010: 28(4); 370-5.

30-  Ozden E, Bostanci Y, Yakupoglu KY, Akdeniz E, Yilmaz AF, Tulek N, Sarikaya S. Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy. Urology. 2009 Jul;74(1):119-23.

31-  Tanyel E, Taşdelen Fişgin N, Esen S, Darka O, Bahçivan M, Leblebicioğlu H, Tülek N. A rare case of endocarditis due to Moraxella catarrhalis in an immunocompetent patient. Mikrobiyol Bul 2009 Oct; 43(4): 667-70.

32-  Tanyel E, Çoban AY, Taşdelen Fışgın N, Tülek N, Durupınar B. In vitro effect of reactive nitrogen and oxygen intermediates alone and combination with some antibiotics against Brucella melitensis isolates. Mikrobiol Bul. 2009, Jan; 43(1):19-26.

33-  Tasdelen Fisgin N, Ergonul O, Doganci L, Tulek N. The role of ribavirin in the therapy of Crimean-Congo hemorrhagic fever: early use is promising. Eur J Clin Microbiol Infect Dis. 2009 Aug; 28(8):929-33.

34-  Tasdelen Fisgin N, Tanyel E, Doganci L, Tulek N. Risk factors for fatality in patients with Crimean-Congo haemorrhagic fever. Trop Doct. 2009 Jul; 39(3):158-60.
35-  Kutlu G, Tuncer Ertem G, CoĢkun Ö, Ergun U, Gomceli YB, Tulek N, Inan LE. Brucella: A cause of peripheral neuropathy. Eur Neurol 2009; 61:33-38.

36-  Tasdelen Fisgin N, Tanriverdi Cayci Y, Coban AY, Ozatli D, Tanyel E, Durupinar B, Tulek N. Antimicrobial activity of plant extract Ankaferd Blood Stopper(R) Fitoterapia. 2009 Jan; 80(1):48-50.

37-  Ergun U, Ertem GT, Kutlu G, Coskun O, Inan LE, Tulek N, Ilhan MN. Visual evoked potentials in neurobrucellosis.Neurosciences (Riyadh). 2008 Oct; 13(4):363-5.

38-  Doganci L, Ceyhan M, Tasdeler NF, Sarikayalar H, Tulek N. Crimean Congo hemorrhagic fever and diffuse alveolar haemorrhage.Trop Doct. 2008; 38(4):252-4.

39-  Aydin B, Tanyel E, Colak B, Tasdelen Fısgin N, Tulek N. Infection control implementations at Forensic Medicine Practice: A Nationwide Survey in Turkey. Am J Forensic Med Pathol 2009 Jun; 30(2):167-70.

40-  Tasdelen Fisgin N, Fisgin T, Tanyel E, Doganci L, Tulek N, Guler N, Duru F. Crimean-Congo hemorrhagic fever: five patients with hemophagocytic syndrome. Am J Hematol. 2008; 83(1):73-6.

41-  Tanyel E, Fisgin NT, Yildiz L, Leblebicioglu H, Doganci L, Tulek N. Panniculitis as the initial manifestation of brucellosis: a case report. Am J Dermatopathol. 2008; 30(2):169-71.

42-  Tanyel E, Tasdelen-Fisgin N, Sarikaya-Genc H, Doganci L, Tulek N. Brucella epididymo-orchitis relapsing three times despite treatment. Int J Infect Dis. 2008; 12(2):215-7.

43-  Adibelli Z, Dilek M, Kocak B, Tülek N, Uzun O, Akpolat T. An unusual presentation of sirolimus associated cough in a renal transplant recipient. Transplant Proc. 2007; 39(10):3463-4.

44-  Coban AY, Tanyel E, Tasdelen Fisgin N, Darka O, Tulek N, Durupinar B. Mutant prevention concentrations of tetracycline, rifampicin and ciprofloxacin for Brucella melitensis. J Chemother. 2007; 19(5):596-8.

45-  Hatipoglu CA, Yetkin MA, Ergin F, Ipekkan K, Erdinc FS, Bulut C, Tülek N, Demir G, Yigit Y, Demiröz AP. Vaccination of healthcare workers against hepatitis B virus in a teaching hospital. J Hosp Infect. 2007; 67(2):200-2.

46-  Tanyel E, Taşdelen Fışgın N, Sarikaya Genç H, Tülek N. A case of secondary syphilis with hepatitis. Mikrobiyol Bul. 2007; 41(2):291-6.

47-  Tanyel E, Coban AY, Koruk ST, Simsek H, Hepsert S, Cirit OS, Tulek N. Actual antibiotic resistance pattern of Brucella melitensis in central Anatolia. An update from an endemic region. Saudi Med J. 2007; 28(8):1239-42.

48-  Yilmaz GR, Cevik MA, Erdinc FS, Ucler S, Tulek N. The risk factors for infections acquired by cerebral hemorrhage and cerebral infarct patients in a neurology intensive care unit in Turkey. Jpn J Infect Dis. 2007; 60(2-3):87-91.

49-  Erdinc FS, Yetkin MA, Ataman Hatipoglu C, Yucel M, Karakoc AE, Cevik MA, Tulek N. Five-year surveillance of nosocomial infections in Ankara Training and Research Hospital. J Hosp Infect. 2006 Dec; 64(4):391-6 Erratum in: J Hosp Infect. 2007 Oct; 67(2):205-6.

50-  Yetkin MA, Bulut C, Erdinc FS, Oral B, Tulek N. Evaluation of the clinical presentations in neurobrucellosis. Int J Infect Dis. 2006; 10(6):446-52.

51-  Iseri S, Bulut C, Yetkin MA, Kinikli S, Demiröz AP, Tülek N. Comparison of the diagnostic value of blood and bone marrow cultures in brucellosis. Mikrobiyol Bul. 2006 Jul; 40(3):201-6.

52-  Yetkin MA, Erdinc FS, Bulut C, Tulek N. Cutaneous anthrax as an occupational disease in Central Anatolia, Turkey. Saudi Med J. 2006; 27(5):737-9.

53-  Turan H, Balci U, Erdinc FS, Tulek N, Germiyanoglu C.Bacteriuria, pyuria and bacteremia frequency following outpatient cystoscopy. Int J Urol. 2006; 13(1):25-8. 

54-  Tulek N, Senocak H, Yetkin A, Un H, Aylan O.Antibody response achieved by different rabies prophylaxis methods. Int J Infect Dis. 2006; 10(1):87-8.

55-  Yetkin MA, Erdinc FS, Bulut C, Tulek N. Epididymoorchitis due to brucellosis in central Anatolia, Turkey. Urol Int. 2005; 75(3):235-8.

56-  Hatipoglu CA, Bilgin G, Tulek N, Kosar U. Pulmonary involvement in brucellosis. J Infect. 2005; 51(2):116-9.

57-  Ertem GT, Tulek N, Oral B, Kinikli S. Therapy of acute hepatitis C with interferon-alpha2b plus ribavirin in a health care worker. Acta Gastroenterol Belg. 2005; 68(1):104-6.

58-  Coskun O, Ertem GT, Ergun U, Kutlu G, Tulek N, Inan LE, Ozkan S. Evaluation of brainstem auditory potential in brucellosis patients with and without neurological involvement. Int J Neurosci. 2005; 115 (5):717-23.

59-  Cevik MA, Yilmaz GR, Erdinc FS, Ucler S, Tulek NE. Relationship between nosocomial infection and mortality in a neurology intensive care unit in Turkey. J Hosp Infect. 2005; 59(4):324-30.

60-  Yildiz F, Tanyel E, Hatipoğlu CA, Ertem GT, Tülek N, Oral B. Evaluation of Brucella tube agglutination test in patients with brucellosis, patients with bacterial infections other than brucellosis and healthy subjects]. Mikrobiyol Bul. 2005 Apr; 39(2):211-7.

61-  Hatipoglu CA, Bayiz U, Firat SK, Erdinç FS, Tülek N, Gedikoglu S. Case report: a case of tularemia with delayed diagnosis. Mikrobiyol Bul. 2005 Jan; 39(1):89-94.

62-  Hatipoglu CA, Yetkin A, Ertem GT, Tulek N. Unusual clinical presentations of brucellosis. Scand J Infect Dis. 2004; 36(9):694-7.

63-  Bulut C, Ertem GT, Gökcek C, Tulek N, Bayar MA, Karakoc E. A rare cause of wound infection: Shewanella putrefaciens. Scand J Infect Dis. 2004; 36(9):692-4.

64-  Tuncer Ertem G, Tülek N, Yetkin MA. Case report: subdural hemorrhage in neurobrucellosis. Mikrobiyol Bul. 2004 Jul; 38(3):253-6.

65-  Ertem GT, Tanyel E, Tulek N, Ulkar GB, Doganci L. Osteoarticular involvement of brucellosis and HLA-B27 antigen frequency in Turkish patients. Diagn Microbiol Infect Dis. 2004; 48(4):243-5.

66-  Piskin G, Akyol A, Uzar H, Tulek N, Boyvat A, Gurgey E. Comparative evaluation of Type 1 latex hypersensitivity in patients with chronic urticaria, rubber factory workers and healthy control subjects. Contact Dermatitis. 2003; 48(5):266-71.

67-  Aliefendioglu D, Erdem G, Tulek N, Yurdakok M. Neonatal and maternal serum levels of soluble ICAM-1 in preeclamptic and normal pregnancies. Am J Perinatol. 2002; 19(6):333-9.

68-  Cengizlier R, Uysal G, Güven A, Tülek N. Herpetic finger infection. Cutis. 2002; 69(4):291-2.

69-  Kiliç D, Tulek N, Tuncer G, Doganci L, Willke A. Antimicrobial susceptibilities and ESBL production rates of Salmonella and Shigella strains in Turkey. Clin Microbiol Infect 2001; 7(6):341-2.

70-  Uysal G, Tülek N, Ozhan B. Leukocyte aggregation score in meningitis and its relationship with cerebrospinal fluid soluble selectin and soluble ICAM-1 levels. J Trop Pediatr. 2000; 46(6):381-2.

71-  Tulek N, Saglam SK, Saglam M, Turkyilmaz R, Yildiz M. Soluble interleukin-2 receptor and interleukin-10 levels in patients with chronic hepatitis B infection. Hepatogastroenterology. 2000; 47(33):828-31

72-  Cengizlier R, Demirpolat E, Tulek N, Cakmak F. Circulating ICAM-1 levels in bronchial asthma and the effect of inhaled corticosteroids. Ann Allergy Asthma Immunol. 2000; 84(5):539-41.

73-  Tulek N, Aydintug O, Ozoran K, Tutkak H, Duzgun N, Duman M, Tokgoz G. Soluble intercellular adhesion molecule-1 (sICAM-1) in patients with systemic lupus erythematosus. Clin Rheumatol. 1996; 15(1):47-50.

74-  Kinikli G, Tülek N, Sentürk T, Turgay M, Tutkak H, Duman M, Tokgöz G. The early effect of specific immunotherapy on lymphocyte response to PHA and allergens in atopic patients with allergic rhinitis. Allergol Immunopathol (Madr). 1996; 24(2):65-9.

75-  Turktas H, Unsal M, Tulek N, Oruc O. Hepatotoxicity of antituberculosis therapy (rifampicin, isoniazid and pyrazinamide) or viral hepatitis. Tuber Lung Dis. 1994; 75(1):58-60.

76-  Ozoran K, Ataman S, Aydintuğ O, Tülek N, Düzgün N. Remitting seronegative symmetrical synovitis with pitting edema: an adult case with excellent prognosis. Rheumatol Int. 1994; 13(5):215-6.

77-   Leblebicioglu H, Eroglu C; Members of the Hepatitis Study Group. Acute hepatitis B virus infection in Turkey: epidemiology and genotype distribution. Clin Microbiol Infect. 2004; 10(6):537-41. (as a member of the study group) HEPATITIS STUDY GROUPE. Aribas (Konya); F. Sirmatel (Gaziantep); C. Ayaz (Diyarbakir); M. F. Ozsoy, S. Cavuslu (Istanbul); R. Turkyilmaz, E. Tutuncu (Ankara); M. Sunbul, S. Esen, D. Turan (Samsun); A. Akbulut, M. Cihangiroglu (Elazig); B. Aygen, O. Yildiz (Kayseri); G. Usluer, E. D. Kartal (Eskisehir); H. Irmak, O. Evirgen (Van); N. Tulek, M. A. Yetkin (Ankara); I Dokmetas, M. Bakir (Sivas); O. Ozgenc (Izmir); M. Parlak, E. Parlak (Erzurum); I. Koksal, R. Caylan (Trabzon); I. Sencan (Duzce); T. Yamazhan, S. Ulusoy (Izmir); Z. Akcam, G. Yayli (Isparta); G. Ersoz, A. Kaya (Mersin); N. Saltoglu, Y. Tasova (Adana); Y. Ersoy (Malatya); D. Kilic, S. Kaygusuz (Kirikkale).

78-  Esen S, Leblebicioglu H. Prevalence of nosocomial infections at intensive care units in Turkey: a multicentre 1-day point prevalence study. Scand J Infect Dis. 2004; 36(2): 144-8. (As a member of study group) and Study Group : H Akalin, M Altindiş, B Arda, D Arman, H Arslan, C Ayaz, K Aydin, B Aygen, G Aygun, Y Bek, S Cavuġlu, Rcaylan, L Dosemeci, E Timurkaynak, S Erol, S Felek, Mf Geyik, S Gundes,Y Heper, F Kahveci, O Ozgenç, O Oncul, I Ozgunes,R Ozturk,M Parlak, A Rahman, R Saba, H Sahġnoğlu, I Sencan, F Sirmatel, Ntahtaci, N Tulek H Turgut, H Turan, S Ulusoy, G Usluer, B Ucel, A Willke, G Yayli, O Yildiz, E Yilmaz, F Yilmaz.

79-  Leblebicioglu H, Esen S; Turkish Nosocomial Urinary Tract Infection Study Group. Hospital-acquired urinary tract infections in Turkey: a nationwide multicenter point prevalence study. J Hosp Infect. 2003; 53(3):207-10. (as a member of the study group) Members of the Turkish Nosocomial Urinary Tract Infection Study Group were: Filiz Akata, Dilek Arman, Celal Ayaz, Bilgehan Aygen, Gokhan Aygun, Mehmet Bakir, NurcanBaykam, Rahmet Caylan, Ilknur Erdem, Mine Erdenizmenl, Funda Ergin, Yasemin Ersoy, Suleymen Felek, Duygu Findik, Sibel Gundes, Ali Kaya, Rabin Saba, Irfan Sencan, Serap Simsek, Yesim Tasova, Necla Tulek, Ozlem Tunger, HuseyinTurgut, Sercan Ulusoy, Gaye Usluer, Cengiz Uzun, Savas Vural, Guler Yayli.

80-  Bakir M, Ugurlu M, Dokuzoguz B, Bodur H, Tasyaran MA, Vahaboglu H and the Turkish CCHF Study. Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures. J Med Microbiol 2005; 54, 385–389. The following people are members of the Turkish CCHF Study Group: Nazif Elaldi, Klinik Bakteriyoloji and Enfeksiyon Hastaliklari AD., Tip Fakultesi, Cumhuriyet Universitesi, Sivas; Nezihe Yilmaz, Viroloji Subesi, RSHM, Ankara; Mustafa Aydın Çevik, Klinik Bakteriyoloji and Enfeksiyon Hastaliklari Dept, Numune Hast., Ankara; Necla Tülek, Klinik Bakteriyoloji and Enfeksiyon Hastaliklari Dept, Ankara Hast., Ankara; Ayhan Kubar, GATA Klinik Bakteriyoloji Ana Bilim Dalı; Levent Akın, Halk Sagclıgcı AD, Hacettepe Universitesi, Ankara; Hakan Leblebicioglu, Klinik Bakteriyoloji and Enfeksiyon Hastaliklari Dept, Tip Fakultesi, OndokuzMayıs Universitesi, Samsun; Ahmet A. Yücaokur, Biyoistatistik AD. Cerrahpasa Tip Fakultesi, Istanbul Universitesi, Istanbul; Recep Ozturk, Klinik Bakteriyoloji and Enfeksiyon Hastaliklari AD. Cerrahpasa Tip Fakultesi, Istanbul Universitesi, Istanbul



II. DIĞER YURT DIŞI İNDEKSLERCE TARANAN DERGILERDE YER ALAN YAYINLAR (articles published in journals indexed other international indexation services):


1-     Ebru Aktepe, Meliha Cağla Sonmezer, Saliha Yarımoğlu, Fatma Şebnem Erdinc, Gunay Ertem, Necla Tulek. Gec Tanı Konulan Ulseroglanduler Tularemi: Bir Olgu Sunumu. Klimik Dergisi 2017; 30(2): 83-6. (Emerging Sources Citation Index).

2-     Metin Özsoy, Necla Tülek, Murat Soyuduru, Meliha Çağla Sönmezer, Esra Kaya Kılıç, Fatma Şebnem Erdinç, Günay Tuncer Ertem, Sami Kınıklı. Evaluation Of Infectious Diseases Consultations Requested By Emergency Service In The Tertiary Care Setting. Nobel Med 2017; 13(2): 48-51 (Emerging Sources Citation Index).

3-     Necla Tülek. Kronik hepatit C tedavisinde yenidoğrudan etkili antiviral ajanlar. Editoriyal görüş. Klimik Dergisi, 2017; 30: 1-1. (Emerging Sources Citation Index).

4-     Temoçin, F, Eren Tülek N, Aktepe E, Erdinç F, Tuncer Ertem G, Demirelli M . "Pneumococcal meningitis in an immunocompromised patient". Ortadoğu Tıp Dergisi 9 (2017): 45-6.

5-     Bulut C, Temocin F, Tülek N, et al. Effect of tenofovir on renal functions in patients with chronic hepatitis B. Ortadogu Medical Journal / Ortadogu Tip Dergisi. 2016; 8(3):123-8.

6-     Koksal E, Tulek N. Moksifloksasinle indüklenen Steven Johnson Sendromu. Klimik Derg 2016; 3: 136-137. (Emerging Sources Citation Index).

7-     Meliha Cağla Sonmezer, Necla Tulek. Bakteriyel infeksiyonlarda ve Sepsiste Biyobelirtecler. Klimik Dergisi 2015; 28(3): 96-102. (Emerging Sources Citation Index).

8-     Ersoy M, Sönmezer Ç, Tulek N. MERS-Co Virüs Enfeksiyonu: Epidemiyoloji ve Son GelişmelerOrtadoğu Tıp Derg2015; 7(3): 140-3.

9-     Meliha Cagla Sonmezer, Necla Tulek, Metin Ozsoy, Fatma Erdinc, Gunay Ertem. Diabetic foot infections: effective microorganisms and factors affecting the frequency of osteomyelitis and amputation. Eur Res J 2015; 1(3):119-27.

10-  Tulek N, Ozsoy M, Moroglu C, et al. Seroprevalance of hepatitis A antibodes among patients with chronic hepatitis B in Turkey. Eurosian J Hepato Gastroenterol 2015; 5(2):95-97. (PubMed)

11-  Çiğdem MOROĞLU, Necla TÜLEK, Ebru AKTEPE, Meliha Çağla SÖNMEZER, Metin ÖZSOY, Günay Ertem TUNCER, Fatma Şebnem ERDĠNÇ, Murat KEKİLLİ. Causes of Acute Exacerbation of Chronic Hepatitis B Infection: A Report of Case Series. Viral Hepat J 2015; 21: 48-51.

12-  Günay Tuncer-Ertem, Murat Sayan, Şirin Hekimoğlu, Necla Tülek. Pegile Ġnterferon, Ribavirin ve Telaprevir Tedavisi Altında Gelişen HCV NS3 İnhibitörü Çapraz Direnci. Klimik Dergisi 2015; 28: 92-4.

13-  Tugba Sari , Fatih Temocin, Meryem Demirelli, Behic Oral and Necla Tulek., A Case of Crimean Congo Hemorrhagic Fever Complicated With Pararenal Abscess. Archives of Clinical Infectious Diseases. 2015 October; 10(4): e28484. (Emerging Sources Citation Index kapsamındaki dergi olup Web of Sciences tarafından izlenmektedir).

14-  Server Yagci, Sukriye Kurkcuoglu, Barıs Dogan Ozturk, Fatma Sebnem Erdinc, Necla Eren Tulek. Small colony variant of methicillin-resistant Staphylococcus aureus isolated from an osteomyelitis case. Journal of Microbiology and Infectious Diseases. 2013; 3 (2): 89-92.

15-  Doganci, L, Fisgin NT, Sarıkaya Genc, H, Tulek N. Fatal tetanus: misdiagnosed & operated as surgical acute abdomen. Case Rep Clin Pract Rev, 2007; 8: 169-71.

16-  Yurdakok M, Aliefendioglu D, Tulek N, Yiğit İ. Interleukin-1, interleukin-6, and tumor necrosis factor in early neonatal respiratory distress syndrome. Egypt J Neonatal 2002; 3(3): 119-20.

17-  Köksalan H, Esen N, Cağatay M, Tülek N, Mert A.[Isolation of Gardnerella vaginalis from vaginal discharge specimens] Mikrobiyol Bul. 1993 Jul;27(3):191-5. (pubmed)

18-  Cağatay M, Tülek N, Köksalan H, Mert A.[Prevalence of hepatitis C virus antibodies in hospital personnel]Mikrobiyol Bul. 1992 Jul;26(3):242-7.(pubmed)

19-  Sengül A, Tutkak H, Tülek N, Özoran K, Düzgün N, Gürler A, Tokgöz G. Tumor necrosis factor-alpha and interleukin-6 levels in Behçet‟s Disease. In: Wechsler B, Godeau P (eds) Behçet‟s Disease. Excerpta Medica International Congress Series Elsevier Science Publishers 1993; pp: 49-52. (Web of Sciences tarafından izlenmektedir).

Gönderen Necla Eren TÜLEK, MD Professor 24 Şubat 2018 Cumartesi